VIGO Photonics signs letter of intent to acquire U.S. infrared detector manufacturer’s assets

The acquisition is part of VIGO’s broader strategy to expand its footprint in the American market. “The planned acquisition is another step in the implementation of our strategy, which assumes, among other things, expansion on the American market,” said Adam Piotrowski, President of the Management Board of VIGO Photonics S.A.

According to the company, the transaction will allow it to dynamically grow its customer base in the U.S., take over ongoing contracts, and significantly boost brand visibility. “Our main goal on the American market is to become a leader in the mid-infrared area,” Piotrowski added.

VIGO has been actively investing in its U.S. operations by developing a local team, establishing organisational structures, and adapting its product offerings to meet local demands. “The year 2024 and the beginning of 2025 brought very good results in this respect,” Piotrowski noted.

In 2024, the company secured 29 new customers in the U.S., including a three-year contract with a key client for seven types of liquid nitrogen (LN2) detection modules. It also fulfilled its first medical industry order and won a major defence contract for detectors used in public safety systems such as schools and offices.

Last year, VIGO signed framework agreements with six new clients in the methane monitoring sector and obtained all necessary certifications for sales to the U.S. Department of Defense and other federal agencies. Early in 2025, the company showcased five new product lines, including its flagship LN2 detectors, at a leading global photonics trade fair.

VIGO sees the U.S. as a high-potential market for detectors across industrial, laboratory, and military applications. “The potential acquisition will significantly accelerate our development in the United States,” said Piotrowski, citing increased customer interest in both current solutions and future innovations.

The letter of intent grants VIGO exclusivity for up to 90 days to complete the transaction, with the possibility of extension. Final terms are contingent on due diligence outcomes and corporate approvals.

VIGO is currently evaluating financing options for the deal, which could include internal funds, debt financing, or a share issue. The company, based in Ożarów Mazowiecki, Poland, has been listed on the Warsaw Stock Exchange since 2014 and employs around 200 specialists, with a subsidiary operating in the U.S.